Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Other Non Operating Income of -$2000.0 in Q3 2025, up 93.33% quarter-over-quarter from -$30000.0 in Q2 2025, and down 109.09% on a YoY basis from $22000.0 in Q3 2024.
Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$2000.0 for Q3 2025.
- In Q3 2025, Other Non Operating Income fell 109.09% year-over-year to -$2000.0; the TTM figure through Sep 2025 stood at -$517000.0 (down 406.86% YoY), while the FY2024 annual figure was -$554000.0, down 551.76% from the prior year.
- Other Non Operating Income was -$2000.0 for Q3 2025 at Dianthus Therapeutics, up from -$30000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $22000.0 in Q3 2024 to a low of -$463000.0 in Q4 2024.
- Historically, Other Non Operating Income has averaged -$66923.1 across 4 years, with a median of -$22000.0 in 2025.
- Biggest YoY gain for Other Non Operating Income was 246.67% in 2024; the steepest drop was 1346.88% in 2024.
- A 4-year view of Other Non Operating Income shows it stood at -$208000.0 in 2022, then jumped by 84.62% to -$32000.0 in 2023, then slumped by 1346.88% to -$463000.0 in 2024, then surged by 99.57% to -$2000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$2000.0 (Q3 2025), -$30000.0 (Q2 2025), and -$22000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | -463,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | -80,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | -32,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -23,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | -208,000.00 |
| Sep 30, 2022 | -2,000.00 |